Abstract: A waterproof battery pack includes a housing, an electronic component, and a connection assembly. The interior of the housing is hollow to form a mounting cavity; the electronic component is mounted in the mounting cavity; and the connection assembly is slidably connected to the housing, the connection assembly includes a first button and a connector, and the first button can be pressed toward the side of the electronic component to drive the connector to be disconnected from a power tool. The waterproof battery pack further includes a waterproof partition located between the connection assembly and the electronic component, where the waterproof partition is connected to the housing to divide the mounting cavity into a first mounting space and a second mounting space that are independent of each other. The connection assembly is mounted in the first mounting space, and the electronic component is mounted in the second mounting space.

Abstract: A particle storage tube (100) used for implanting microparticles into a body in cooperation with a puncture needle (500), and comprising an accommodation portion (1) and a drug delivery portion (2). The accommodation portion (1) is an elongated hollow tube having a channel (10) used to accommodate microparticles (4). One end of the accommodation portion (1) is connected to the drug delivery portion (2), and the other end of the accommodation portion (1) is an open part (11) used to discharge the microparticles out of the particle storage tube (100). The inner diameter of the channel (10) is 1.0-1.8 times the inner diameter of a lumen (502) of the puncture needle (500). An inner chamber (20) of the drug delivery portion (2) is in communication with the channel (10), and is used for delivering liquid medicine (200) to the channel (10).

Abstract: Provided is a bispecific antibody, comprising a first antigen-binding moiety and a second antigen-binding moiety, wherein a paired domain of the first antigen-binding moiety comprises an amino acid sequence of engineered HLA-I ?3 and an amino acid sequence of engineered ?2M. Also provided are an expression method for the bispecific antibody, a polynucleotide encoding the bispecific antibody, a vector and host cell containing the polynucleotide, a pharmaceutical composition containing the bispecific antibody, a fusion protein, and a conjugate.

Abstract: A deformable structure includes a first deformable layer, and a material of the first deformable layer includes a deformable material. The deformable material includes a plurality of sheet structures that are stacked, and each sheet structure includes a plurality of aldolases. A molecular model of an aldolase is equivalent to a square on a plane where the sheet structure is located, and the aldolase has amino acid residues at each of four corners thereof. In one sheet structure, amino acid residues at four corners of each aldolase are connected to amino acid residues of four aldolases around the aldolase through four disulfide bonds, respectively. In two adjacent sheet structures, amino acid residues of two adjacent aldolases are connected through at least one disulfide bond.

Abstract: The present disclosure provides a power management device, including an initial voltage input terminal, a power management circuit, and a plurality of gamma correction circuits. The initial voltage input terminal is configured to provide an initial voltage; the power management circuit includes at least one follower amplifier sub-circuit, each follower amplifier sub-circuit is configured to output a corresponding target operating voltage according to the initial voltage, a reference voltage, and a target operating voltage setting parameter; and each gamma correction circuit is configured to output a corresponding gamma correction voltage according to the initial voltage, the reference voltage, and a corresponding gamma parameter. The present disclosure further provides a display device.

Abstract: Disclosed is a packaging device. Since a distance from a first top surface of a side plate to a surface of a bottom plate is greater than a distance from a second top surface to the surface of the bottom plate, that is, a top surface of the side plate of a box body is designed into an outer convex and inner concave structure, through subsequent reasonable design of sizes of the first top surface, the second top surface and a first slope surface and an angle of the first slope surface, when a box cover and the box body match, the box body and the box cover can match more closely.

Abstract: The present disclosure provides a power management device, including an initial voltage input terminal, a power management circuit, and a plurality of gamma correction circuits. The initial voltage input terminal is configured to provide an initial voltage; the power management circuit includes at least one follower amplifier sub-circuit, each follower amplifier sub-circuit is configured to output a corresponding target operating voltage according to the initial voltage, a reference voltage, and a target operating voltage setting parameter; and each gamma correction circuit is configured to output a corresponding gamma correction voltage according to the initial voltage, the reference voltage, and a corresponding gamma parameter. The present disclosure further provides a display device.

Abstract: Provided is a cushion, including a cushion body, a first antislip film and a second antislip film, wherein a first surface of the first antislip film is connected to a first surface of the cushion body; a first surface of the second antislip film is connected to a second surface of the cushion body; the first surface of the cushion body is opposite to the second surface of the cushion body; and a second surface of the first antislip film and a second surface of the second antislip film are configured to respectively abut surfaces of two objects spaced apart by the cushion. A transportation protective device is also provided.

Abstract: Disclosed is a method for preparing a precursor of a recombinant human insulin or an analogue thereof, comprising: a. bacterial fermentation, centrifuging a fermentation broth in a continuous flow to collect a supernatant; b. filtering the supernatant in step (a) by means of a hollow fiber membrane and collecting the filtrate; and c. purifying the filtrate in the step (b) by means of a chromatography column. The method has the advantages of streamlined steps, scalability, no use of organic solvents, high yield, etc. The purity of the insulin precursor can exceed 90%, the host cell protein removal rate exceeds 90%, and the exogenous DNA removal rate is 89% or greater, achieving less than 0.1 ng/mg.

Abstract: A deformable structure includes a first deformable layer, and a material of the first deformable layer includes a deformable material. The deformable material includes a plurality of sheet structures that are stacked, and each sheet structure includes a plurality of aldolases. A molecular model of an aldolase is equivalent to a square on a plane where the sheet structure is located, and the aldolase has amino acid residues at each of four corners thereof. In one sheet structure, amino acid residues at four corners of each aldolase are connected to amino acid residues of four aldolases around the aldolase through four disulfide bonds, respectively. In two adjacent sheet structures, amino acid residues of two adjacent aldolases are connected through at least one disulfide bond.